How Trump Exemplifies Our Ableist Culture
By Steven W. Thrasher,
Scientific American
| 10. 07. 2020
It was a grotesque sight: the president of the United States preening from the White House balcony, his mask pulled defiantly off his face, able to infect anyone around him with the novel coronavirus. He had just been released from Walter Reed hospital, after he’d tweeted that we shouldn’t “be afraid of COVID” or “let it dominate your life”—as if it hadn’t already killed more than 200,000 people in the United States alone, including a dear friend of mine.
The coming narrative was depressing, predictable and sadly bipartisan: the president was virtue-signaling that he was a strong man who had beat a terrible disease. He hadn’t let COVID-19 win—he’d crushed it. He was dancing on the graves of people who had let themselves die because they were weak. Like gloating Jair Bolsonaro after he’d defeated the virus on Brazil’s COVID-19 battlefield, President Donald J. Trump was now a COVID survivor—and if he could be, so could you. If you encountered the coronavirus, had “good genes,” and were just plain strong enough, Trump seemed to be saying...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
